A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Study Drug in Patients with Mild to Moderate Dementia Alzheimer’s Type

A Multicenter, Randomized, Double-Blind Study on the Effects of Study Drug on Overweight Patients Treated with Study Drug for Schizophrenia or Schizoaffective Disorder

Multicenter, Randomized, Parallel-Group, Double-Blind, Phase III Comparison of the Efficacy and Safety of Study Drug to Placebo When Used as Adjunct to Mood Stabilizers (Lithium or Valproate) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients

An International, Multi-centre, Double-blind, Randomised, Parallel-Group, Placebo-controlled, Phase III Study of the Efficacy and Safety of Study Drug and Paroxetine as Monotherapy in Adult Patients with Bipolar Depression and Study Drug in Continuation

An Eight-Week, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety and Tolerability of One Fixed 100 mg Dose of Study Drug in Patients with Major Depressive Disorder

Effectiveness of Switching from Injectable Conventional Antipsychotic Medications to Injectable Resperidone (Schizophrenia)

Effectiveness of Switching from Polypharmacy to Monotherapy (Schizophrenia)

A Phase 3 Multicenter, Randomized, Double Blind, Placebo Controlled Study of the Effect of Daily Treatment with Study Drug on Measures of Cognition, Activities of Daily Living and Global Function in Subjects with Mild Dementia of the Alzheimer’s Type